SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318306-14-000018
Filing Date
2014-05-12
Accepted
2014-05-12 17:11:09
Documents
9
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10Q a10q-033114.htm 10-Q 431219
2 CEO/CFO CERTIFICATION ex_31-1.htm EX-31.1 16242
3 CEO/CFO CERTIFICATION ex_32-1.htm EX-32.1 6183
  Complete submission text file 0000318306-14-000018.txt   2273911

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE REPORT accp-20140331.xml EX-101.INS 241318
5 XBRL TAXONOMY SCHEMA accp-20140331.xsd EX-101.SCH 15023
6 XBRL CALCULATION LINKBASE accp-20140331_cal.xml EX-101.CAL 34587
7 XBRL DEFINITION LINKBASE accp-20140331_def.xml EX-101.DEF 81270
8 XBRL LABEL LINKBASE accp-20140331_lab.xml EX-101.LAB 213657
9 XBRL PRESENTATION LINKBASE accp-20140331_pre.xml EX-101.PRE 141985
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1025
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 14834313
SIC: 2834 Pharmaceutical Preparations